Mustang Bio Announces Phase 1/2 Clinical Trial Data of MB-106, a First-in-Class CD20-targeted, Autologous CAR T Cell Therapy, to be Presented at 11th International Workshop for Waldenstrom's Macroglobulinemia
October 27, 2022 08:00 ET
|
Mustang Bio, Inc.
MB-106 demonstrated 100% overall response rate in Waldenstrom macroglobulinemia Data to be presented by Fred Hutch’s Dr. Mazyar Shadman WORCESTER, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) --...
Urica Therapeutics Appoints Seasoned Biotech Executive Jay D. Kranzler, M.D., Ph.D., as Chairman and Chief Executive Officer
October 03, 2022 08:00 ET
|
Fortress Biotech, Inc.
MIAMI, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Urica Therapeutics, Inc. (“Urica” or the “Company”) (formerly known as UR-1 Therapeutics, Inc.), a Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”)...
Fortress Biotech Announces Closing of Acquisition of Caelum Biosciences by AstraZeneca
October 06, 2021 08:00 ET
|
Fortress Biotech, Inc.
Triggers upfront payment of approximately $150 million to Caelum shareholders, of which approximately $64 million is payable to Fortress Biotech1 NEW YORK and BORDENTOWN, N.J., Oct. 06, 2021 ...
NASDAQ: FBIO Investor Notice: Lawsuit against Fortress Biotech, Inc. announced by Shareholders Foundation
March 30, 2021 07:25 ET
|
Shareholders Foundation, Inc.
SAN DIEGO, March 30, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NASDAQ: FBIO shares. Investors, who purchased shares of...
DEADLINE ALERT for FBIO, SPLK, and BSX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
January 25, 2021 11:30 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 25, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for FBIO, SPLK, and BSX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
January 21, 2021 11:00 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for YY, LRN, and FBIO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
January 11, 2021 11:00 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 11, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action - FBIO
January 08, 2021 19:15 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO) between December 11, 2019...
DEADLINE ALERT for YY, LRN, and FBIO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
January 04, 2021 11:00 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 04, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for YY, LRN, and FBIO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
December 28, 2020 11:15 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Dec. 28, 2020 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...